Paper833596
Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment.
Hyttel J. J Neurochem, 1977. Cited by 26 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment. Papers, record 833596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/833596
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 3,4-Dihydroxyphenylacetic Acid | Major topic |
| Corpus Striatum | Major topic |
| Homovanillic Acid | Major topic |
| Phenylacetates | Major topic |
| Piperazines | Major topic |
| Thioxanthenes | Major topic |
| Tranquilizing Agents | Major topic |
| Animals | |
| Male | |
| Mice | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,271,447 | Striatal dopamine turnover and L-dopa treatment after short-term exposure of rats to manganese. | Arch Toxicol | 1981 | https://conductscience.org/library/papers/7271447 | PubMed |
| 6,431,472 | Response changes after repeated low apomorphine: dopamine autoreceptor desensitization or learning? | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6431472 | PubMed |
| 6,126,896 | Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6126896 | PubMed |
| 2,501,819 | Regional homovanillic acid levels and oral movements in rats following chronic haloperidol treatment. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2501819 | PubMed |
| 220,654 | Tardive dyskinesia: a clinical test of the supersensitivity hypothesis. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/220654 | PubMed |
| 111,273 | Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/111273 | PubMed |
| 32,570 | Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment. | Psychopharmacology (Berl) | 1978 | https://conductscience.org/library/papers/32570 | PubMed |
| 14,353 | Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics. | Psychopharmacology (Berl) | 1977 | https://conductscience.org/library/papers/14353 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/833596
GET https://conductscience.org/api/papers/v1/833596/authors